MISSISSAUGA, Ontario TheNewswire – March 10, 2021 Sire Bioscience Inc. (CSE:SIRE) (CNSX:SIRE.CN) (OTC:BLLXF) (FSE:BR1B) (“Sire” or the “Company”) announces that, in response to the ongoing global COVID-19 pandemic, it will host its annual general and special meeting of shareholders (the “ Meeting ”) by teleconference only, at 11:00 am Pacific Standard Time on Friday, April 9, 2021.

The Company made the decision to hold the Meeting by teleconference after considering Provincial and Federal guidance regarding public gatherings, and to proactively protect the health and wellbeing of the Company’s shareholders, officers, directors and service providers that will participate in the Meeting.

The Company encourages its shareholders to vote their common shares before the proxy cut-off date of Wednesday, April 7, 2021 at 11 am PST and reminds its shareholders that no votes will be accepted at the Meeting.

Shareholders who wish to attend the Meeting can find the details to attend below.

Conference Dial-in Number: 1-888-299-2873 (toll free in Canada) or 1-888-585-9008 (toll-free in the USA)

Conference Room #: 448-444-850

Dial in for any other countries, please contact the Company at 604.737.2303 prior to the Meeting date for dial in particulars.

How to Vote:

  • – Registered shareholders of the Company will be able to vote their common shares online at www.investorvote.com or by telephone (1-866-732-VOTE (8683) (Toll Free)).  The Registered shareholders will require their control number which can be found on their proxy form that will be mailed out to the Company’s shareholders on or before Friday, March 19, 2021.

    – Non-objecting beneficial (“ NOBO ”) shareholders of the Company will be able to vote common shares online at www.investorvote.com or by telephone (1-866-734-VOTE (8683) (Toll Free)).  The NOBO holders will require their control number which can be found on their voting instruction form.

    – Objecting beneficial shareholders of the Company must contact their broker directly to obtain their proxy form to vote their common shares.

About Sire Bioscience Inc.

Sire is headquartered in Mississauga, Ontario, and is managed by a group of successful entrepreneurs who have extensive experience in the areas of consumer-packaged goods, manufacturing, logistics, and distribution. Sire is a CPG life science company focused on the plant-based foods and supplements industry.

For additional information contact:

Sire Bioscience Inc.
Brian Polla, CEO
T:  416.669.9392
E: ir@sirebioscience.com
W: sirebioscience.com
Socials: @sirebioscience

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2021 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less